Express Scripts Holding ROE 2006-2018 | ESRX

Current and historical return on equity (ROE) values for Express Scripts Holding (ESRX) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical Services $0.009B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.385B 24.78
PRA Health Sciences (PRAH) United States $6.397B 30.63
Charles River Laboratories (CRL) United States $5.770B 22.42
HealthEquity (HQY) United States $5.057B 107.25
INC Research Holdings (SYNH) United States $5.000B 22.01
Premier (PINC) United States $4.939B 19.98
Teladoc (TDOC) United States $4.310B 0.00
NovoCure (NVCR) Jersey $3.311B 0.00
AMN Healthcare Services Inc (AMN) United States $2.893B 22.06
Intrexon (XON) United States $1.855B 0.00
BioTelemetry (BEAT) United States $1.640B 45.46
Medpace Holdings (MEDP) United States $1.638B 26.05
IKang Healthcare (KANG) China $1.421B 78.73
Healthways (TVTY) United States $1.380B 19.55
Natera (NTRA) United States $1.247B 0.00
China Cord Blood (CO) China $1.009B 27.00
Apollo Medical Holdings (AMEH) United States $0.850B 0.00
Surgery Partners (SGRY) United States $0.692B 0.00
Civitas Solutions (CIVI) United States $0.590B 15.05
CareDx (CDNA) United States $0.442B 0.00
OncoCyte (OCX) United States $0.118B 0.00
Interpace Diagnostics (IDXG) United States $0.028B 0.00
Cancer Genetics (CGIX) United States $0.025B 0.00
Biocept (BIOC) United States $0.014B 0.00
OpGen (OPGN) United States $0.012B 0.00
FORM Holdings (XSPA) United States $0.009B 0.00